Healthpeak Properties, Inc. (DOC)
(Delayed Data from NYSE)
$18.34 USD
-0.29 (-1.56%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $18.36 +0.02 (0.11%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth D Momentum D VGM
Price, Consensus and EPS Surprise
DOC 18.34 -0.29(-1.56%)
Will DOC be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for DOC based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for DOC
Healthpeak (DOC) Q1 FFO and Revenues Surpass Estimates
Alexandria (ARE) Beats Q1 AFFO Estimates, Narrows '24 Guidance
DOC: What are Zacks experts saying now?
Zacks Private Portfolio Services
What's in the Cards for Healthpeak (DOC) This Earnings Season?
Should Investors Retain Healthpeak (DOC) Stock for Now?
Here's What Key Metrics Tell Us About Physicians Realty Trust (DOC) Q4 Earnings
Other News for DOC
Scotiabank Sticks to Their Buy Rating for Healthpeak Properties (DOC)
Healthpeak: Q1 Earnings Snapshot
Healthpeak Properties Reports First Quarter 2024 Results and Declares Quarterly Cash Dividend on Common Stock
DOC Stock Earnings: Healthpeak Properties Beats Revenue for Q1 2024
Buy Rating Affirmed for Healthpeak Properties Amid Strong Q1 Performance and Raised Financial Guidance